Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300–7.e302.
Bai T, Fang F, Li F, Ren Y, Hu J, Cao J. Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis. BMC Geriatr. 2020;20:279.
Article PubMed PubMed Central Google Scholar
Han K, Park YM, Kwon HS, Ko SH, Lee SH, Yim HW, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS ONE. 2014;9:e86902.
Article PubMed PubMed Central Google Scholar
Quan Y, Wang C, Wang L, Li G. Geriatric sarcopenia is associated with hypertension: a systematic review and meta-analysis. J Clin Hypertens. 2023;25:808–16.
Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the national institute on aging. Front Physiol. 2020;11:963.
Article PubMed PubMed Central Google Scholar
Jung HN, Cho YK, Kim HS, Kim EH, Lee MJ, Lee WJ, et al. Association between hypertension and myosteatosis evaluated by abdominal computed tomography. Hypertens Res. 2023;46:845–55.
Chen K, Zhou M, Wang X, Li S, Yang D. The role of myokines and adipokines in hypertension and hypertension-related complications. Hypertens Res. 2019;42:1544–51.
Article CAS PubMed PubMed Central Google Scholar
Ishikawa J, Toba A, Futami S, Saito Y, Tamura Y, Araki A, et al. Association of pulse pressure and mean blood pressure to frailty, sarcopenia, and cognitive dysfunction in elderly outpatients with history of hypertension. Hypertens Res. 2024;47:2029–40. https://doi.org/10.1038/s41440-024-01684-w.
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet. 2021;398:1053–64.
Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385:1268–79.
Article CAS PubMed Google Scholar
Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315:2673–82.
Article CAS PubMed PubMed Central Google Scholar
Streit S, Poortvliet RKE, Gussekloo J. Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old. Data from the Leiden 85-plus Study. Age Ageing. 2018;47:545–50.
Kremer KM, Braisch U, Rothenbacher D, Denkinger M, Dallmeier D. Systolic blood pressure and mortality in community-dwelling older adults: frailty as an effect modifier. Hypertension. 2022;79:24–32.
Article CAS PubMed Google Scholar
Masoli JAH, Delgado J, Pilling L, Strain D, Melzer D. Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality. Age Ageing. 2020;49:807–13.
Article PubMed PubMed Central Google Scholar
Wang HY, Wang J, Wang Q, Yang C, Huang Y, Chen M. Blood pressure in the longevous population with different status of hypertension and frailty. Hypertens Res. 2024;47:959–69.
Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.
Article CAS PubMed Google Scholar
Mirzai S, Persits I, Kazibwe R, Gabani M, Seals A, Singleton MJ, et al. Relationship between sarcopenia and intensive blood pressure control efficacy and safety: a secondary analysis of SPRINT. Hypertension. 2024;81:e77–e87.
Article CAS PubMed Google Scholar
Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.
Article CAS PubMed Google Scholar
Hwang IC, Kim CH, Kim JY, Choi HM, Yoon YE, Cho GY. Rate of change in 10-year atherosclerotic cardiovascular disease risk and its implications for primary prevention. Hypertension. 2023;80:1697–706.
Article CAS PubMed Google Scholar
Colón-Emeric CS, McDermott CL, Lee DS, Berry SD. Risk assessment and prevention of falls in older community-dwelling adults: a review. Jama 2024;331:1397–406.
Sturnieks DL, Hicks C, Smith N, Ratanapongleka M, Menant J, Turner J, et al. Exergame and cognitive training for preventing falls in community-dwelling older people: a randomized controlled trial. Nat Med. 2024;30:98–105.
Article CAS PubMed Google Scholar
Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C, et al. Sarcopenia and cardiovascular diseases. Circulation 2023;147:1534–53.
Article PubMed PubMed Central Google Scholar
Xiang B, Zhou Y, Wu X, Zhou X. Association of device-measured physical activity with cardiovascular outcomes in individuals with hypertension. Hypertension. 2023;80:2455–63.
Article CAS PubMed Google Scholar
Miller CR, Wactawski-Wende J, Manson JE, Haring B, Hovey KM, Laddu D, et al. Walking volume and speed are inversely associated with incidence of treated hypertension in postmenopausal women. Hypertension. 2020;76:1435–43.
Article CAS PubMed Google Scholar
Zhou B, Fang Z, Zheng G, Chen X, Liu M, Zuo L, et al. The objectively measured walking speed and risk of hypertension in Chinese older adults: a prospective cohort study. Hypertens Res. 2024;47:322–30.
Ishikawa J, Toba A, Tamura Y, Araki A, Harada K. Changes in blood pressure associated with frailty and sarcopenia in elderly outpatients with cardiometabolic diseases. Geriatr Gerontol Int. 2023;23:506–16.
留言 (0)